scholarly article | Q13442814 |
P356 | DOI | 10.1002/IJC.2910630407 |
P8608 | Fatcat ID | release_sg5qlwapkze2jogdfdfl5zz5oy |
P953 | full work available at URL | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.2910630407 |
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.2910630407 | ||
P698 | PubMed publication ID | 7591257 |
P2093 | author name string | Y. Hayashi | |
S. Kobayashi | |||
T. Sugimoto | |||
M. Ohki | |||
R. Hanada | |||
T. Taki | |||
K. Ida | |||
F. Bessho | |||
S. Yamamori | |||
P2860 | cites work | The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts | Q57756648 |
Exacerbation of psoriasis with meclofenamate | Q71804176 | ||
Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor | Q72428441 | ||
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours | Q24298221 | ||
The erg gene: a human gene related to the ets oncogene | Q24299030 | ||
Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma | Q24309359 | ||
EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts | Q24317557 | ||
The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1 | Q24629399 | ||
A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG | Q28252253 | ||
Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. | Q34114085 | ||
Variability of EWS chimaeric transcripts in Ewing tumours: a comparison of clinical and molecular data. | Q36080250 | ||
Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. | Q36374350 | ||
An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(16;21) chromosomal translocation | Q36644089 | ||
Combinatorial generation of variable fusion proteins in the Ewing family of tumours. | Q40874946 | ||
Neuronal Differentiation of Ewing's Sarcoma Induced by Cholera Toxin B and Bromodeoxyuridine—Establishment of Ewing's Sarcoma Cell Line and Histochemical Study— | Q41671997 | ||
Detection of the (11;22)(q24;q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction | Q42027940 | ||
Cell culture of small round cell tumor originating in the thoracopulmonary region. Evidence for derivation from a primitive pluripotent cell | Q42816400 | ||
P4510 | describes a project that uses | SK-N-MC | Q54954478 |
SK-N-PI | Q54954481 | ||
ES-1-OT | Q54832434 | ||
KP-EW-MS | Q54900378 | ||
KP-EW-YI | Q54900379 | ||
SCCH-196 | Q54952377 | ||
SCMC-ES1 | Q54952450 | ||
SCMC-ES2 | Q54952451 | ||
SK-N-LO | Q54954476 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | neuroectodermal tumor | Q3542016 |
cell line | Q21014462 | ||
P304 | page(s) | 500-504 | |
P577 | publication date | 1995-11-01 | |
1995-11-15 | |||
P1433 | published in | International Journal of Cancer | Q332492 |
P1476 | title | EWS-FLI-1 and EWS-ERG chimeric mRNAs in Ewing's sarcoma and primitive neuroectodermal tumor | |
EWS‐FLI‐1 and EWS‐ERG chimeric mRNAs in Ewing's sarcoma and primitive neuroectodermal tumor | |||
P478 | volume | 63 |
Q38298497 | A method for accurate detection of translocation junctions in Ewing family of tumors |
Q77344066 | A novel EWS-ERG rearrangement generating two hybrid mRNAs in a peripheral primitive neuroectodermal tumour (pPNET) with a t(15;22) translocation |
Q34121076 | Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors |
Q74360528 | Alterations of the tumour suppressor gene DCC in neuroblastoma |
Q40649283 | Diagnostic Significance and Clinical Applications of Chimeric Genes in Ewing's Sarcoma |
Q22011151 | ESE-3, a novel member of an epithelium-specific ets transcription factor subfamily, demonstrates different target gene specificity from ESE-1 |
Q37289163 | ETS-1-mediated transcriptional up-regulation of CD44 is required for sphingosine-1-phosphate receptor subtype 3-stimulated chemotaxis |
Q35785944 | Engagement of CD99 induces apoptosis through a calcineurin-independent pathway in Ewing's sarcoma cells. |
Q28513779 | Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia |
Q30990686 | Genetic and molecular abnormalities in tumors of the bone and soft tissues |
Q39692770 | Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF. |
Q33988757 | Modulation of androgen receptor signaling in hormonal therapy-resistant prostate cancer cell lines |
Q34801108 | Molecular diagnosis in Ewing family tumors: the Rizzoli experience--222 consecutive cases in four years |
Q40627036 | Newly established Askin tumor cell line and overexpression of focal adhesion kinase in Ewing sarcoma family of tumors cell lines |
Q52852427 | Ploidy and karyotype complexity are powerful prognostic indicators in the Ewing's sarcoma family of tumors: a study by the United Kingdom Cancer Cytogenetics and the Children's Cancer and Leukaemia Group. |
Q46421700 | Population-based genetic alterations in Ewing's tumors from Japanese and European Caucasian patients |
Q38912800 | Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis |
Q37305155 | The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis |
Q37669484 | Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas |
Q34105989 | Updates on cytogenetics and molecular genetics of bone and soft tissue tumors: Ewing sarcoma and peripheral primitive neuroectodermal tumors |